Keyron: Funding, Investors & Team (Oct 2026)
Keyron is a company that specializes in developing innovative medical devices and technology aimed at effectively treating metabolic diseases. Their patented ForePass device has shown promising results in reversing type 2 diabetes, NASH, and obesity in animal studies, with complete reversal of insulin resistance demonstrated. The company's findings have been published in The Lancet EBioMedicine, and they plan to conduct clinical trials in South America before expanding to the United States.
Keyron has raised $30k across 1 funding round on record, the most recent a Seed of $30k announced in Sep 2024.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Keyron Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Keyron Funding Rounds
Keyron Founders and Leadership Team
Contact details for the Keyron team: 1 of 1 has an email address on file.
Start 14-day free trial →Keyron Funding Compared to Other Health Care Startups
Keyron's latest round of $30k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Keyron in Health Care and London
Companies Similar to Keyron
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Keyron Funding FAQs
What does Keyron do?
Keyron is a company that specializes in developing innovative medical devices and technology aimed at effectively treating metabolic diseases. Their patented ForePass device has shown promising results in reversing type 2 diabetes, NASH, and obesity in animal studies, with complete reversal of insulin resistance demonstrated. The company's findings have been published in The Lancet EBioMedicine, and they plan to conduct clinical trials in South America before expanding to the United States.
How much funding has Keyron raised?
Keyron has raised $30k across 1 round on record. The most recent is a Seed of $30k announced in Sep 2024.
When did Keyron last raise funding?
Keyron's most recent funding round on record is a Seed of $30k, announced in Sep 2024.
Who founded Keyron?
FundedIQ lists Michael Holder (Founder) at Keyron.
Where is Keyron headquartered?
Keyron is based in London, England, United Kingdom.
How many employees does Keyron have?
Keyron is in the 1-10 employee band.
How does Keyron's funding compare to other Health Care startups?
Keyron's latest round of $30k is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Keyron Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Keyron is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.